Endocrinology Grand Rounds (May 19, 2023)

This event has passed and can no longer be viewed

This event was presented live or live-streamed and has not been designated for on-demand presentation.

This Endocrine Grand Rounds session will take place on Friday, May 19, 2023 at 12:00 p.m. Attendance will only be available through Zoom.

Activity Information

Needs Statement

Physicians, fellows, residents, physician assistants, nurse practitioners, nurses, and other healthcare professionals need to receive regular updates on professional guidelines, advances in basic science and clinical research, and emerging treatment modalities and management strategies for patients with endocrine disorders. The series will explore new models of multidisciplinary care in the field, especially as it relates to patients with cardiometabolic diseases such as obesity and diabetes. The series aims to expand the knowledge of learners, promote adherence to evidence-based guidelines, enhance the quality of endocrinology care, disseminate best clinical practices, and improve patient outcomes.

Educational Objectives

Impact of Inpatient Glycemic Control on Covid-19 Outcomes in Cancer Patients

At the conclusion of the session, the participants should be able to:

  • Assess the impact of inpatient glycemic control on Covid-related mortality in cancer patients.
  • Determine the relationship of inpatient glycemic control and Covid-related outcomes in cancer patients.
  • Identify whether pre-existing diabetes in cancer patients hospitalized for Covid-19 with inpatient hyperglycemia affect Covid-related outcomes.

Increasing Usage of Insulin Order Set and Updated Inpatient Insulin Pump Usage Guidelines

At the conclusion of the session, the participants should be able to:

  • Describe the interventions used in the quality improvement project.
  • Discuss the clinical relevance of the quality improvement project.
  • Recognize the clinical indications to continue insulin pump in the inpatient setting.

Impact of Inpatient Glycemic Control on Covid-19 Outcomes in Cancer Patients

At the conclusion of the session, the participants should be able to:

  • Investigate the effects of testosterone therapy on body composition in men in different body-mass index (BMI) categories.
  • Investigate the effects of testosterone therapy on metabolic profile in men in different BMI categories.
  • Investigate the effects of testosterone therapy on BMD/bone turnover markers in men in different BMI categories.

Target Audience

Professional Categories

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Nurses
  • Other Health Professionals

Specialties

  • Internal Medicine

Interest Groups

  • Hospital Medicine

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Directors

  1. Eric Deal, M.D. Placeholder Image

    Eric Deal, M.D.

    Assistant Professor
    Baylor College of Medicine
  2. Mark Herman, M.D.

    Mark Herman, M.D.

    Associate Professor, E.L. Wagner MD Chair of Internal Medicine
    Baylor College of Medicine

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenters

  1. Emmeline Ngo, M.D. Placeholder Image

    Emmeline Ngo, M.D.

    Endocrinology Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Son Nguyen, D.O. Placeholder Image

    Son Nguyen, D.O.

    Endocrinology Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Maryam Tetlay, M.D. Placeholder Image

    Maryam Tetlay, M.D.

    Endocrinology Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Activity Directors

  1. Eric Deal, M.D. Placeholder Image

    Eric Deal, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Mark Herman, M.D.

    Mark Herman, M.D.

    Associate Professor, E.L. Wagner MD Chair of Internal Medicine
    Baylor College of Medicine

    Disclosure:
    • Research Support: Eli Lilly and Co.

Planning Committee Members

  1. Layla Abushamat, M.D., M.P.H.

    Layla Abushamat, M.D., M.P.H.

    Instructor, Medicine − Atherosclerosis and Lipoprotein Research
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Eric Deal, M.D. Placeholder Image

    Eric Deal, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Jordana Faruqi, M.D., M.P.H. Placeholder Image

    Jordana Faruqi, M.D., M.P.H.

    Endocrinology Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  4. Sean Hartig, Ph.D.

    Sean Hartig, Ph.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. Mark Herman, M.D.

    Mark Herman, M.D.

    Associate Professor, E.L. Wagner MD Chair of Internal Medicine
    Baylor College of Medicine

    Disclosure:
    • Research Support: Eli Lilly and Co.
  6. Maryam Tetlay, M.D. Placeholder Image

    Maryam Tetlay, M.D.

    Endocrinology Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Presenters:

Emmeline Ngo, M.D.

Endocrinology Fellow Baylor College of Medicine

Son Nguyen, D.O.

Endocrinology Fellow Baylor College of Medicine

Maryam Tetlay, M.D.

Endocrinology Fellow Baylor College of Medicine

Health Topics

You May Also Be Interested In

In Person
Live Stream
Upcoming
Michael E. DeBakey VAMC/CTRID Research Seminar Series
Activity Date Range: 10/3/24
Activity Available In Person / Activity Available in via Streaming
Credit 1.00 Continuing Medical Education Credits Available
Upcoming
Barrow Neurological Institute – Neurology Case Conference
Activity Date Range: 9/13/24
Credit 1.00 Continuing Medical Education Credits Available
Upcoming
Barrow Neurological Institute – Neurology Case Conference
Activity Date Range: 10/11/24
Credit 1.00 Continuing Medical Education Credits Available